Product NDC: | 0591-2229 |
Proprietary Name: | Metoclopramide Hydrochloride |
Non Proprietary Name: | Metoclopramide Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Metoclopramide Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-2229 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071250 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081223 |
Package NDC: | 0591-2229-05 |
Package Description: | 500 TABLET in 1 BOTTLE, PLASTIC (0591-2229-05) |
NDC Code | 0591-2229-05 |
Proprietary Name | Metoclopramide Hydrochloride |
Package Description | 500 TABLET in 1 BOTTLE, PLASTIC (0591-2229-05) |
Product NDC | 0591-2229 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Metoclopramide Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20081223 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |